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Sensorineural Deafness Minireview
and Pigmentation Genes: Melanocytes
and the Mitf Transcriptional Network
In mammalian development, the ear arises from a co-
alescence of ectoderm, mesoderm, endoderm, and neu-
ral crest–derived cells. Initially, an ectodermal placode
invaginates to form a pouch of cells called the otocyst.
The otocyst resides between the first and second bra-
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chial arches of the embryo. Paraxial mesoderm and neu-Boston, Massachusetts 02115
ral crest that underlie the epithelial covering of these
brachial arches develop into the muscles and bones of
the middle ear. These constituents of the middle ear are
Pigment Cells in the Ear contained within a mucosa-lined cavity derived from
Nearly half of individuals with hearing impairment are endoderm of the first pharyngeal pouch and connected
deaf from birth, and a large proportion of these results to the oral cavity by the eustasian tube. The otocyst
from genetic lesions. Nearly one in 2000 children is either eventually develops into the sensory organ in the inner
born deaf or will become deaf as a result of genetic ear that senses both motion through the semi circular
defects. In recent decades, much progress has been canals and sound through the cochlea. Neural crest–
made in determining the genes and pathways involved derived melanocytes are contained within a blood ves-
in hereditary deafness. While the precise biological func- sel–rich zone of the cochlea known as the stria vas-
tion of many of these genes remain enigmatic, it appears cularis. This zone appears to participate in modulating
that mutations in these genes affect diverse aspects of the chemical composition of endolymph, potentially
ear development, structure, and function. Just as the through mechanisms, which exploit its considerable
identification of these gene loci has helped us under- vascularity. Numerous genes regulating diverse cell
stand the pathological basis of various forms of heredi- types that in total contribute to the formation or mainte-
tary deafness, we have gained much insight into basis nance of this remarkable organ system can cause inher-
biology and function of the auditory system, and from ited or syndromic deafness. Among the deafness genes,
this, some surprises have emerged. the subtypes affecting melanocytes have revealed unex-
One rather unexpected finding was that it has pected, but essential roles for this cell type in the devel-
emerged that hearing and pigmentation of the skin and opment and function of the inner ear.
fur may share some common ground and that a tiny White Spotting Mutants with Deafness
population of melanocytes within the inner ear is essen- in Human and Mouse
tial for hearing. But just how these melanocytes facilitate After noting a concordance of deafness and pigmenta-
the physiology of hearing remains enigmatic. During the tion defects in his patient population, the Dutch ophthal-
past decade, a collection of syndromic deafness genes mologist Petrus Waardenburg systematically surveyed
have been identified at the molecular level including a institutions housing the deaf in his country, and in 1951
striking subset that produces both deafness and sys- was able to assign phenotypically similar patients to the
temic pigment cell abnormalities. These genes that reg- autosomal dominant inherited deafness syndrome that
ulate hearing have provided genetic and molecular han- bears his name. Eventually four related syndromes were
dles for the elucidation of a fascinating regulatory defined and designated WS types I–IV. All four subtypes
pathway made up of a novel group of transcriptional are characterized by deafness, as well as patchy hypo-
and signaling factors. pigmentation of the skin, hair, and iris, but only the WS
Sound waves enter the ear through the external audi- type II (MIM#193510 [Online Mendelian Inheritance in
tory canal (Figure 1A) causing vibrations of the tympanic Man at http://www.ncbi.nlm.nih.gov:80/entrez/query.
membrane. These vibrations are in turn conveyed fcgi?db5OMIM]) phenotype is limited to these features.
The severity of the deafness can vary dramatically fromthrough the middle ear by a series of three bones called
mild to profound, unilateral or bilateral due to uncertainossicles, culminating at the fluid-filled cochlea in the
genetic or environmental influences (see below).inner ear, where the vibrations are transmitted through
In contrast, the other three subtypes (types I, III, andthe endolymphatic fluid (Figure 1B). Particular ampli-
IV) display abnormalities in addition to hypopigmenta-tudes cause movements of specific length cilia that
tion and deafness. In addition to abnormal pigmentationcrown subsets of hair cells lining the spiral cochlea (Fig-
and deafness, WSI (WSI, MIM#193500) patients exhibiture 1C). These cells are bathed in potassium-rich endo-
a craniofacial defect called dystopia canthorum, andlymph. Movement of the cilia causes mechanosensory
WSIII (also called Klein-Waardenburg Syndrome,ion channels to open, allowing flow of potassium ions
MIM#148820) patients display musculo-skeletal man-into the hair cells triggering depolarization, firing an ac-
ifestations including limb deformities. Patients withtion potential down the nerve fibers into the spiral gan-
WSIV, Sha-Waardenburg Syndrome (MIM#277580), pre-glion and out to the brain where the original pressure
sent with deafness and hypopigmentation accompaniedwaves are finally perceived as sound.
by Hirschsprung’s Disease, characterized by megaco-
lon due to congenital deficiency of neural crest derived
enteric ganglia. Thus, the abnormality in WSII appears‡ To whom correspondence should be addressed (e-mail:
to constitute a core deafness/pigment defect whereasdavid_fisher@dfci.harvard.edu).
§ Present address: CombinatoRx, Inc. the other subtypes affect the same deafness/pigment
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Figure 1. Anatomy of the Ear
(A) Coronal cross section. Sound moves through the pinna, external canal, tympanic membrane, ossicles, and into the endolymphatic fluid
contained within the cochlea (inner ear). Transduced vibrations of the appropriate amplitude bend particular sized cilia on hair cells causing
a physical opening of ion channels and movement of potassium ions into the hair cells, triggering neuronal firings.
(B) A cross section of the cochlea reveals three sections.
(C) The potassium-rich endolymph filled chamber is conditioned by the stria vascularis, made up of intermediate cells (neural crest derived
melanocytes) sandwiched between marginal and basal cells. One wall of this chamber is lined by the motion-sensing hair cells.
(D and E) Regulatory schematic of human syndromic deafness conditions associated with hypopigmentation. Top focuses on clinical overlaps
and divergences (D); bottom focuses on molecular relationships of genes implicated in each syndrome (E).
phenotype as well as additional distinct organ systems sion of Mitf in neural crest development. Importantly, the
existence of many WSII patients who lack Mitf mutations(Figure 1D).
While genetic studies of these human syndromes have (80%) predicts the existence of other as yet unidentified
gene(s) essential for proper melanocyte development orgenerated numerous critical insights into our under-
standing of the molecular basis of melanocyte develop- function (reviewed in Read and Newton, 1997).
Mitf Is a Central Mediator of Melanocyte Developmentment and its role in deafness, significant breakthroughs
have also come from analyses of abnormally pigmented Recent studies have identified functional and epistatic
connections between many of the Waardenburg Syn-mice. A handful of pigment loci, namely the white spot-
ting loci, are essential for proper melanocyte develop- drome genes, yielding a clear view of the molecular
networks regulating melanocyte development and func-ment, proliferation, or survival, and their analysis has
provided a gateway into the molecular mechanisms con- tion. Most if not all of these factors mechanistically con-
verge on Mitf, either upstream or downstream (Figuretrolling melanocyte growth and differentiation. Among
these latter mutants reside the subgroup that affect 2), suggesting that Mitf plays a pivotal role in integrating
extracellular signals into changes in gene expressionhearing.
The splotch locus in mouse encodes a paired-homeo- necessary during melanocyte development and postna-
tal function. Furthermore, Mitf may be sufficient to drivebox containing transcription factor called Pax3. Muta-
tion of Pax3 in humans leads to WSI or III. The severity the melanocyte developmental program. Stable overex-
pression of Mitf in NIH3T3 cells produced morphologicof Pax3 mouse and human mutant phenotypes reflects
the widespread expression of Pax3 early in development changes and expression of pigment synthetic genes
consistent with melanocytic transformation (Tachibanain cell types other than melanocytes. In contrast, WSIV
is either associated with mutation of the transcription et al., 1996).
Mitf expression is detectable in melanocyte precur-factor Sox10, the cytokine Endothelin 3 (Edn3), or its
receptor EDNRB, each of which has been implicated in sors early (E10) after neural tube exit (Opdecamp et
al., 1997), placing Mitf in a position to integrate earlyearly neural crest development in a fashion capable of
affecting both melanocytes and enteric ganglial cells. developmental cues. Recent data have shown that both
the transcription factors Pax3 (Watanabe et al., 1998)Finally, individuals afflicted with WSII or the highly re-
lated and more severe pigmentation/deafness disorder and Sox10 (Bondurand et al., 2000; Lee et al., 2000;
Potterf et al., 2000; Verastegui et al., 2000) upregulateTeitz-Smith Syndrome (MIM#103500) have been shown
to carry mutations in the human homolog of the white Mitf expression through consensus elements in the Mitf
promoter in melanocytes (Figure 2C). These activitiesspotting locus, Mitf. The melanocyte-specific phenotype
in WSII likely reflects the melanocyte-restricted expres- likely underlie the phenotypic overlap seen in Waarden-
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of the c-Kit receptor tyrosine kinase. The murine c-Kit
homolog is encoded by the white dominant spotting locus
(W), and its ligand is encoded by another white spotting
locus, Steel. Kit and Steel mutant mice display both pig-
mentation and deafness phenotypic overlap with Mitf. It
is plausible that the Waardenburg phenotype of Endothelin
3 and endothelin receptor B mutations in humans is a
reflection of the same MAP kinase–dependent pathway
to Mitf, which is employed by Steel/Kit.
The growing number of extracellular signals recog-
nized to modulate Mitf thus highlight its key role in early
stages of melanocyte development. But Mitf expression
also persists in mature skin melanocytes and most (if
not all) melanomas (King et al., 1999), suggesting that
Mitf may also play a postdevelopmental role in the mela-
nocyte. For example, mice carrying the Mitf vit mutant
allele (D222N, very mild effect on dimerization/DNA bind-
ing [Hemesath et al., 1994] leading to weak loss of function)
(Figure 2B) displays accelerated postnatal graying and
deafness, suggesting that Mitf may also function in mela-
nocyte survival or proliferation in the adult.
Melanocyte Function in the Ear
While it now seems clear that mutations in genes that
affect melanocyte development and function, such asFigure 2. Mitf Is Essential for Pre- and Postnatal Melanocyte Prolif-
eration/Development Mitf, c-Kit, and Steel, are associated with sensorineural
deafness and play a role in ear development, the precise(A) Mice carrying the semidominant Mitf mi allele, which disrupts
DNA binding. The heterozygote Mitf mi/1 (left) displays a white patch function of cochlear melanocytes in the stria vascularis
devoid of melanocytes, and the homozygote (right) completely lacks remains uncertain. Inner ear function does not depend
melanocytes from birth. on pigment production from melanocytes, since the al-
(B) Mice carrying the recessive allele Mitf vit, which weakly affects
bino mouse displays normal hearing, even though itDNA binding. 7-month-old siblings, one a heterozygote Mitf vit/1 (left)
lacks all pigment due to a lack of tyrosinase function.is normally pigmented, and the other, a homozygote Mitf vit/Mitf vit
The albino mouse, in contrast to the microphthalmia(right) is gray due to progressive loss of melanocytes after birth.
(C) Multiple syndromic deafness/pigmentation genes converge on mouse, which lacks all melanocytes, carries a full com-
Mitf. The Mitf promoter is responsive to Sox 10, Pax3, TCF/b-cat- plement of melanocytes. This difference implies a sec-
enin, and CREB. The latter two receive input from the Wnt and ond, fundamental role for Mitf in proliferation and/or
MSH signaling pathways, respectively. Posttranslationally, Mitf is survival of the melanocyte lineage, a function, which has
targeted by the Steel/Kit/MAPK/Rsk or GSK3b signaling pathways
been now demonstrated in a wide variety of vertebratewhose disruption produces similar melanocyte deficiency as Mitf
species including mammals, birds, and fish.mutation.
So, what is the precise role of melanocyte in auditory
function? Some clues have come from the melanocyte-
burg types I and III (Pax 3 mutations) and type IV (Sox deficient mice. The mice display a measurable alteration
10) as compared to type II (Mitf ). in the ionic composition of endolymph, the extracellular
Another regulator of Mitf expression is the major hor- inner ear fluid that bathes the mechanosensory hair cells
monal modulator of pigment synthesis, melanocyte (Steel, 1995). Normal endolymph is high in K1 ions and
stimulating hormone (MSH). In response to MSH stimu- low in Na1, which establishes an endocochlear potential
lation, increased cAMP produces CREB/ATF-depen- critical for depolarization and auditory nerve electrical
dent activation of the Mitf promoter (Bertolotto et al., signal transduction. Deficiencies in cochlear melano-
1998; Price et al., 1998), likely followed by subsequent cytes are associated with correspondingly low K1 com-
Mitf-mediated transcriptional stimulation of pigmenta- position in endolymph, implying that these melanocytes
tion genes. In addition, the Wnt pathway is important in directly or indirectly facilitate K1 transport. Such a lack
melanocytic development. Wnt signals upregulate the of K1 in the endolymph would be expected to affect the
zebrafish and human Mitf promoters via consensus TCF/ capacity of hair cells response to sound induced motion
Lef/b-catenin elements (Figure 2) (Dorsky et al., 2000; of the endolymph.
Takeda et al., 2000b). In contrast, GSK3b, a negative Does this phenotype result from a developmental de-
regulator of the Wnt pathway, has been found to modu- fect secondary to loss of melanocytes or might this
late DNA binding activity by phosphorylation of Mitf reflect a regulatory role for melanocytes (and, by exten-
(Takeda et al., 2000a). sion, genes in the Mitf transcriptional pathway) in main-
Mitf is also regulated posttranslationally through a taining endolymph composition? In fact, while the pre-
series of MAP kinase–mediated phosphorylations trig- cise role of Mitf in these processes remain enigmatic,
gered by c-Kit stimulation, which appear to modulate it does seem likely that Mitf plays an ongoing postdevel-
Mitf’s activity as well as its stability (Hemesath et al., opmental role in cochlear function since, as mentioned,
1998; Wu et al., 2000; Xu et al., 2000). Woolf Syndrome, the Mitf vit mouse allele (see Figure 2B) displays postnatal
a human pigmentation/deafness disorder closely related age-dependent hearing loss.
Assuming such a regulatory role, one might proposeto Waardenburg Syndrome, is associated with mutation
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that the ability to modulate Mitf activity through an un- will be interesting to determine whether related events
derstanding of melanocytic signal transduction could contribute to hearing loss in the elderly. As with other
potentially have clinical applications. For example, deaf- developmentally critical factors, transcriptional regula-
ness due to Mitf deficiency in WSII (a dominantly in- tion by Mitf is clearly impacted by genetic modifier
herited condition) is the consequence of Mitf haploin- genes, which largely remain to be elucidated. Study of
sufficiency (Tachibana, 1997). Given this, in principal, Mitf’s roles in melanocyte development should serve
modulation of the extracellular signaling pathways that both as a useful model for analyzing lineage develop-
upregulate the melanocyte-specific Mitf promoter (such ment, as well as in providing clues to pathogenesis and
as MSH) might permit therapeutic upregulation of the even therapy of sensorineural deafness in humans.
remaining wild-type Mitf allele. Pharmacologic mimick-
Referencesing of MSH-type Mitf induction might raise Mitf levels
to a threshold required to either improve melanocyte
Bertolotto, C., Abbe, P., Hemesath, T.J., Bille, K., Fisher, D.E., Or-survival during neural crest migration, or enhance exist-
tonne, J.P., and Ballotti, R. (1998). J. Cell Biol. 142, 827–835.
ing cochlear melanocyte-dependent maintenance of K1
Bondurand, N., Pingault, V., Goerich, D.E., Lemort, N., Sock, E.,
in the endolymph, postnatally. Such intervention might Caignec, C.L., Wegner, M., and Goossens, M. (2000). Hum. Mol.
even prove effective in the setting of Waardenburg Syn- Genet. 9, 1907–1917.
drome caused by Pax3 or Sox10 heterozygous muta- Dorsky, R.I., Raible, D.W., and Moon, R.T. (2000). Genes Dev. 14,
tions, which due to their epistatic position would cause 158–162.
reduced levels of Mitf. In this context of partial Pax3/ Hemesath, T.J., Steingrimsson, E., McGill, G., Hansen, M.J., Vaught,
Sox10 function, the Mitf promoter may still be upregu- J., Hodgkinson, C.A., Arnheiter, H., Copeland, N.G., Jenkins, N.A.,
and Fisher, D.E. (1994). Genes Dev. 8, 2770–2780.lated by increased MSH signaling.
Hemesath, T.J., Price, E.R., Takemoto, C., Badalian, T., and Fisher,Of course, it is uncertain when during development
D.E. (1998). Nature 391, 298–301.haploinsufficiency of Mitf is physiologically relevant, or
King, R., Weilbaecher, K.N., McGill, G., Cooley, E., Mihm, M., andwhether there is a reversible component to the deafness.
Fisher, D.E. (1999). Am. J. Pathol. 155, 731–738.The age-dependent deafness seen with the Mitf vit allele
Lee, M., Goodall, J., Verastegui, C., Ballotti, R., and Goding, C.R.suggests an active role for Mitf in the adult cochlea.
(2000). J. Biol. Chem. 275, 37978–37983.Likewise, it is also clear that different genetic back-
Opdecamp, K., Nakayama, A., Nguyen, M.T., Hodgkinson, C.A., Pa-grounds presumably through the action of as yet un-
van, W.J., and Arnheiter, H. (1997). Development 124, 2377–2386.known genetic modifiers, can influence the penetrance
Potterf, S.B., Furumura, M., Dunn, K.J., Arnheiter, H., and Pavan,and severity of the phenotype. The threshold of Mitf
W.J. (2000). Hum. Genet. 107, 1–6.
activity that can prevent hypopigmentation and deaf-
Price, E.R., Horstmann, M.A., Wells, A.G., Weilbaecher, K.N., Take-ness varies between species. Mice carrying a single null
moto, C.M., Landis, M.W., and Fisher, D.E. (1998). J. Biol. Chem.
mutant Mitf allele are indistinguishable from wild-type 273, 33042–33047.
littermates, yet in humans this condition causes WSII. Read, A.P., and Newton, V.E. (1997). J. Med. Genet. 34, 656–665.
Furthermore, more severe deletion of a single arginine
Steel, K.P. (1995). Annu. Rev. Genet. 29, 675–701.
in Mitf’s DNA binding basic region renders dimers un-
Tachibana, M. (1997). Pigment Cell Res. 10, 25–33.
able to bind DNA (dominant-negative) and causes white
Tachibana, M., Takeda, K., Nobukuni, Y., Urabe, K., Long, J.E., Mey-spotting in heterozygous mice (Figure 2A), but a more
ers, K.A., Aaronson, S.A., and Miki, T. (1996). Nat. Genet. 14, 50–54.
profound melanocyte loss with severe deafness in het-
Takeda, K., Takemoto, C., Kobayashi, I., Watanabe, A., Nobukuni,
erozygous humans with Teitz syndrome. With the argi- Y., Fisher, D.E., and Tachibana, M. (2000a). Hum. Mol. Genet. 9,
nine deletion in mouse or the null mutation in human, 125–132.
there is presumably just enough Mitf activity from the Takeda, K., Yasumoto, K., Takada, R., Takada, S., Watanabe, K.,
remaining wild-type allele in the heterozygote to pro- Udono, T., Saito, H., Takahashi, K., and Shibahara, S. (2000b). J.
duce a partial phenotype. Biol. Chem. 275, 14013–14016.
Questions and Prospects Verastegui, C., Bille, K., Ortonne, J.P., and Ballotti, R. (2000). J. Biol.
Chem. 275, 30757–30760.However, before we can even begin to consider the Mitf
and its interacting signaling cascades as targets for Watanabe, A., Takeda, K., Ploplis, B., and Tachibana, M. (1998).
Nat. Genet. 18, 283–286.potential therapeutics, there are still many questions
that remain to be answered. An essential remaining goal Wu, M., Hemesath, T.J., Takemoto, C.M., Horstmann, M.A., Wells,
A.G., Price, E.R., Fisher, D.Z., and Fisher, D.E. (2000). Genes Dev.is the identification of Mitf transcriptional targets in the
14, 301–312.contexts of its specific physiologic activities, such as
Xu, W., Gong, L., Haddad, M.M., Bischof, O., Campisi, J., Yeh, E.T.,modulation of endolymphatic K1. Do cochlear melano-
and Medrano, E.E. (2000). Exp. Cell Res. 255, 135–143.cytes directly pump K1 into endolymph, and, if so, does
Mitf participate in the transcription of such pump genes?
Or does Mitf play a more generic role in influencing
melanocyte proliferation or survival by regulation of as
yet unidentified Mitf transcriptional targets? If cochlear
melanocytes only indirectly modulate endolymphatic
K1, is it the structural presence of melanocytes that is
essential, or are there specific melanocytic factors
which permit K1 secretion by surrounding cells?
Age-related deafness in humans can clearly arise from
multiple causes, but it is intriguing that melanocyte loss
is the norm with age, particularly within hair follicles. It
